Thursday, Jan 11, 2024 · SEC filings
What the smart money revealed on Jan 11
290 insider filings came in. We hid 49 planned (10b5-1) sellers and 185 people whose filings were routine, like grants and tax withholding.
Dyne Therapeutics (DYN) Director Dirk Kersten bought $30M
1.71M shares on the open market. Not a grant or an option exercise.
Agree Realty (ADC) Executive Chairman of Board Richard Agree bought $657K
10,500 shares on the open market. Not a grant or an option exercise.
MainStay CBRE Global Infrastructure Megatrends Term Fund (MEGI) Director Jacques Perold bought $76.7K
5,700 shares on the open market. Not a grant or an option exercise.
Flat Rock Opportunity Fund (FROPX) CEO Robert Grunewald bought $62K
3,267 shares on the open market. Not a grant or an option exercise.
Symbotic (SYM) Senior Vice President Michael Dunn sold $2.99M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 136,822 shares directly.
Atlassian (TEAM) Co-CEO Michael Cannon-Brookes sold $2M
Not marked as a planned 10b5-1 sale. Sold 2% of the shares they held directly. Still holds 445,014 shares.
Atlassian (TEAM) Co-CEO Scott Farquhar sold $2M
Not marked as a planned 10b5-1 sale. Sold 2% of the shares they held directly. Still holds 445,014 shares.
Show 7 more real buys
Show 31 more real sales
13F season
Holdings as of Dec 31, 2023 are due Feb 14
49 funds have filed so far. 40 filed for the quarter before.
Biggest real insider buys, Jan 5–11
Open-market buys by officers and directors, filed in the 7 days up to Jan 11.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.